Antengene Presents Four Preclinical Posters at AACR 2024
- Written by PR Newswire
![]() |
SHANGHAI and HONG KONG, April 6, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced the presentation of four pre...
Read more: Antengene Presents Four Preclinical Posters at AACR 2024















